Esperion Therapeutics Stock Discussion

SuIIIIT :

Youngman : Right. It should at 4 dollars by now

SuIIIIT :

Fortune Smiles 88 : I agree. Low risk high gain opportunity. Retail price for one month nexletol/nexlizer cost $400 per patient. Assuming just 1m patients in USA alone, will net Esperian gross sales of $400m a months or close to half a billion annually. Extrapolate it to global population. Potential is immense.

Youngman : Let's go!

HH1000 : what are you talking about?

StockAmateur OP : if you pay attention to the chart, every time it goes to resistance area. It always stopped with a flat high and being forced to go lower, it happens so many times already

HH1000 : no...it's Powell's speech.  the entire market dropped.

StockAmateur HH1000 : ban him from speech

比特币骗子勿扰 : Fool, when others rise, you drop proactively, now that others have fallen, just follow the fall. Let's see how much you can drop!

72792912 OP : In my opinion, the profit potential of this stock is not large.

72792912 OP 比特币骗子勿扰 : I will basically no longer buy pharmaceutical stocks in the future because the risk is too high.

比特币骗子勿扰 72792912 OP : This stock is being manipulated heavily.

72792912 OP : Yes.

Youngman : Seems like every time they mention something about their financing  some people get spooked  lol

StockAmateur : what's your entry? I'm at 2.370.. kinda worry now